BRITISH BIO TECHNOLOGY innovation strategy

Patent filings in countries

#	Country	Total Patents
#1	United Kingdom	104
#2	WIPO (World Intellectual Property Organization)	59
#3	South Africa	30
#4	Australia	29
#5	EPO (European Patent Office)	29
#6	United States	24
#7	Norway	21
#8	Canada	18
#9	New Zealand	17
#10	Finland	14
#11	Ireland	12
#12	Portugal	9
#13	Denmark	6
#14	Hungary	6
#15	Israel	3
#16	Taiwan	3
#17	Spain	2
#18	Republic of Korea	2

#	Industry
#1	Organic fine chemistry
#2	Pharmaceuticals
#3	Biotechnology
#4	Foods and drinks
#5	Environmental technology
#6	Micro-structure and nano-technology

#	Technology
#1	Therapeutic chemical compounds
#2	Heterocyclic compounds
#3	Medical preparations
#4	Acyclic or carbocyclic compounds
#5	Peptides
#6	Microorganisms
#7	Special acyclic compounds
#8	Enzymes
#9	Climate change mitigation in goods production
#10	Nanostructure applications

Publication	Filing date	Title
GB9415619D0	1994-08-02	Metalloprotease inhibitors
GB9414392D0	1994-07-15	Retroviral expression system
GB9413751D0	1994-07-07	Immunodominant peptides
GB9413566D0	1994-07-06	Metalloproteinase inhibitors
GB9412131D0	1994-06-17	Thrombolytic composition
GB9412207D0	1994-06-17	Pharmaceutical formations
GB9410802D0	1994-05-28	Metalloproteinase inhibitors
GB9408369D0	1994-04-23	Oral administration of protein drugs
US5530161A	1994-02-14	Hydroxamic acid based collagenase inhibitors
GB9401097D0	1994-01-21	Polyether derivatives as metalloproteinase inhibitors
GB9401129D0	1994-01-21	Hydroxamic acid derivatives as metalloproteinase inhibitors
GB9401034D0	1994-01-20	Metalloproteinase inhibitors
WO9416084A1	1994-01-13	Hybrid particle-forming protein comprising a particle-inducing segment and a plurality of antigens
GB9324252D0	1993-11-25	Pharmaceutical use
GB9323162D0	1993-11-10	4-(1h-2-methylimidazo(4,5-c)pyridinylmethyl)phenylsulphonamid e derivatives as antagonists of paf
US5688664A	1993-10-29	Thrombin activatable plasminogen analogues
GB9320660D0	1993-10-07	Inhibition of cytokine production
GB9320360D0	1993-10-02	Hydroxamic acid derivatives as metalloproteinase inhibitors
GB9319573D0	1993-09-22	Proteinaceous particles
ES2075797A1	1993-08-18	Derivatives of therapeutically active hydroxamic acids, procedure for their preparation, pharmaceutical compositions that contain them and the use of such compounds in medicine.